Vaccinex Inc. (VCNX) Company Sales

Vaccinex, Inc. is developing immunotherapy for oncology and neuropathologies through clinical partnerships, accelerating antibody testing. This chart reflects the company's sales on the GURU.Markets platform, where 0.00 determines the latest valuation metric. Patents for semaphorin blocking create monopoly potential in the treatment of Alzheimer's disease, while the business expands its network of medical centers to build a future customer base.

vaccinex.com (VCNX): Company Revenue from 07/04/2022 to 12/28/2024

Analytical breakdowns for Vaccinex Inc. (VCNX)

- stock value and consensus price forecast:

Stock Quotes vaccinex.com|VCNX - Price Target Chart

- market capitalization details:

Market Valuation Vaccinex Inc|VCNX - Real Price to Acquire Entire Company

- balance sheet equity data:

Book Value per Share Vaccinex|VCNX - Company Book Value|Capitalization to Book Value Ratio vaccinex.com|VCNX - Aggregate Company Assets

- debt obligations and liquidity statistics:

- net income and valuation ratios data:

VCNX - Company Net Income|Expected Net Income Vaccinex, Inc.|VCNX - P/E Multiple|Forward P/E Multiple Vaccinex Inc.|VCNX - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio Vaccinex Inc|VCNX - Operating profit before deduction of amortization|Net earnings per one share for the last twelve months Vaccinex|VCNX - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months vaccinex.com|VCNX - Earnings growth in current year|Earnings growth forecast for next year Vaccinex, Inc.

- sales volume and revenue indicators:

VCNX - Revenue and Sales Volume|Company Future Sales Volume Vaccinex, Inc.|VCNX - P/S Multiple|Forward Price-to-Revenue Multiple Vaccinex Inc.|VCNX - Sales Growth YoY (TTM)

General company analysis:Vaccinex, Inc., VCNX

Daily trading volume reflects the asset's actual operational strength, serving as an impartial indicator of liquidity and the fundamental quality of corporate management. By analyzing the sales chart of Vaccinex, Inc. (VCNX), investors assess the stability of the trading flow as a basis for growth forecasting, which is critical for Vaccinex, Inc. given its dependence on clinical success and R&D partnerships in the development of therapies for neurodegenerative diseases.

Key competitors